The EPS projection of Carter's, Inc. (NYSE:CRI) for quarter ended 2016-09-30 is $1.79. Last week, the projection for EPS was $1.79 against target of $1.79, a month earlier. While 2-months ago, this projection was $1.79 versus forecast of $1.79a quarter months earlier, posting a deviation of 0%.
Carter's, Inc. (NYSE:CRI) posted that 18 days earlier, the share price was revised 3 times on upside. In addition, negative revisions were 0.
In last week, negative EPS revisions were 0 times and positive EPS revisions were 0 times. In last one-month and two month the positive revisions were 0 and 0. While in last 120 and 90 days, positive revisions were 4, and 4, correspondingly.
The per-share earnings downgrade for Carter's, Inc. (NYSE:CRI) in the preceding 30 and 120 were 0 and 0. While in 60 and 90 days were 0, and 0, in that order.
Carter's, Inc. (NYSE:CRI) EPS target was $1.79 for the quarter closed 1. It was based on 5 calls. As on 2016-04-28 the EPS was $1.05. The change was $0.06, posting a deviation of 6.06%. The price projections gave a standard deviation of 0.02.
Quarterly Sales Estimates
Carter's, Inc. (NYSE:CRI) sales prediction for the fiscal 2016 stands at $936.166 and the median estimate is at $928. Almost 3 analysts gave sales target.
Among this, the highest sales estimate is $953.3 while the lowest target is $927.2 showing standard deviation of 14.843%.
As many as 3 analysts have positive sales targets revision while 3 reduced sales estimates, posting a deviation of 0%.
Last month, 3 experts have positive sales number revision. Also, 3 research groups lowered the sales projections, posting a deviation of 0%.
A quarter ago, 3 hiked sales target and 3 reduced sales forecast, posting a deviation of 0.183%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...